Skip to main content

Free Content Evaluating the effects of providing financial incentives to tuberculosis patients and health providers in China

SETTING: A project was implemented in 50 low-income counties of Shanxi, where transport incentives were provided to poor patients for their first visit for tuberculosis (TB) diagnosis as well as for referral and supervision incentives for doctors.

OBJECTIVE: To evaluate the effects of providing incentives on TB case detection and treatment.

METHODS: A group of 51 control counties in Shanxi comparable to the intervention counties was selected. Routine TB reporting was reviewed at baseline (January–September 2004) and during the project period (January–September 2005) in both groups. A patient survey was conducted in two counties in each group, with interviews of 119 new smear-positive patients treated during the intervention.

RESULTS: Patients who received travel incentives had an annual individual income similar to those who did not. The notification rates of new smear-positive cases improved in both groups; however, improvement was less marked in the intervention group (70%) than in the control group (99%). Travel incentives did not reduce patient and doctor delays in the intervention group compared with the control group (P > 0.05).

CONCLUSION: Providing incentives was not effective in improving TB control. There are two possible reasons for this: the poor were not well-targeted due to a lack of operational tools, and more influential health systems issues were not addressed.

Keywords: China; Fidelis; financial incentives; poverty; tuberculosis

Document Type: Regular Paper

Affiliations: 1: Office of Epidemiological Study, China National Centre for Disease Control, Beijing, China; and Nuffield Centre for International Health and Development, University of Leeds, Leeds, UK 2: Nuffield Centre for International Health and Development, University of Leeds, Leeds, UK 3: China National Centre for Disease Control, Beijing, China 4: National Centre for TB Control and Prevention, China National Centre for Disease Control, Beijing, China

Publication date: October 1, 2008

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content